Efficacy of low-dose isotretinoin in acne vulgaris

Indian Journal of Dermatology, Venereology and Leprology

Volumn 76, Issue 1, 2010, Pages 7-13

  Sardana, Kabir ^a   Garg, Vijay ^a  

^a MAULANA AZAD MEDICAL COLLEGE   (India)

Author keywords

Acne vulgaris; Efficacy; Low dose isotretinoin

Indexed keywords

CLINDAMYCIN; ISOTRETINOIN;

ACNE VULGARIS; DISEASE SEVERITY; DRUG EFFICACY; ENZYME BLOOD LEVEL; HUMAN; HYPERLIPIDEMIA; LOW DRUG DOSE; PATIENT SELECTION; RELAPSE; REVIEW; SIDE EFFECT; TREATMENT DURATION;

ACNE VULGARIS; ADMINISTRATION, TOPICAL; ANIMALS; HUMANS; ISOTRETINOIN;

EID: 77949886763     PISSN: 03786323     EISSN: 09733922     Source Type: Journal    
DOI: 10.4103/0378-6323.58672     Document Type: Review

References (35)

1. Cunliffe WJ, van de Kerkhof PC, Caputo R, Cavicchini S, Cooper A, Fyrand OL, et al. Roaccutane treatment guidelines; Results of an international survey. Dermatology 1997;194:351-357
2. Pochi PE, Shalita AR, Strauss JS, Webster SB, Cunliffe WJ, Katz HI, et al. Report of the consensus conference on Acne classification. Washington, D.C., March 24 and 25, 1990. J Am Acad Dermatol 1991;24:495-500.
3. Dreno B, Bodokh I, Chivot M, Daniel F, Humbert P, Poli F, et al. [ECLA grading: A system of acne classification for every day dermatological [practice] Ann Dermatol Venereol 1999;126:136-141
4. Goulden V, Clark SM, McGeown C, Cunliffe WJ. Treatment of acne with intermittent isotretinoin. Br J Dermatol 1997;137:106-108
5. Seukeran DC, Cunliffe WJ. Acne vulgaris in the elderly; the response to low-dose isotretinoin. Br J Dermatol 1998;139:99-101.
6. Palmer RA, Sidhu S, Goodwin PG. 'Microdose' isotretinoin. Br J Dermatol 2000;143:205-206
7. Hermes B, Praetel C, Henz BM. Medium dose isotretinoin for the treatment of acne. J Eur Acad Dermatol Venereol 1998;11:117-121
8. Mandekou-Lefaki I, Delli F, Teknetzis A, Euthimiadou R, Karakatsanis G. Low-dose schema of isotretinoin in acne vulgaris. Int J Clin Pharmacol Res 2003;23:41-46
9. Amichai B, Shemer A, Grunwald MH. Low-dose isotretinoin in the treatment of acne vulgaris. J Am Acad Dermatol 2006;54:644-646
10. Bellosta M, Vignini M, Miori L, Rabbiosi G. Low-dose isotretinoin in severe acne. Int J Tissue React 1987;9:443-446
11. Sardana K, Sehgal VN. Retinoids: Fascinating up-and-coming scenario. J Dermatol 2003;30:355-380
12. Kaymak Y, Ilter N. The effectiveness of intermittent isotretinoin treatment in mild or moderate acne. J Eur Acad Dermatol Venereol 2006;20:1256-1260
13. Altman RS, Altman LJ, Altman JS. A proposed set of new guidelines for routine blood tests during isotretinoin therapy for acne vulgaris. Dermatology 2002;204:232-235
14. Plewig G, Dressel H, Pfleger M, Michelsen S, Kligman AM. Low dose isotretinoin combined with tretinoin is effective to correct abnormalities of acne. J Dtsch Dermatol Ges 2004;2:31-45.
15. Geissler SE, Michelsen S, Plewig G. Very low dose isotretinoin is effective in controlling seborrhoea. J Dtsch Dermatol Ges 2003;1:952-958
16. Amichai B. Long-term mini-doses of isotretinoin in the treatment of relapsing acne. J Dermatol 2003;30:572.
17. Strauss JS, Leyden JJ, Lucky AW, Lookingbill DP, Drake LA, Hanifin JM, et al. A randomized trial of the efficacy of a new micronized formulation versus a standard formulation of isotretinoin in patients with severe recalcitrant nodular acne. J Am Acad Dermatol 2001;45:187-195
18. Akman A, Durusoy C, Senturk M, Koc CK, Soyturk D, Alpsoy E. Treatment of acne with intermittent and conventional isotretinoin: A randomized, controlled multicenter study. Arch Dermatol Res 2007;299:467-473
19. Sardana K, Garg VK, Sehgal VN, Mahajan S, Bhushan P. Efficacy of fixed low-dose isotretinoin (20 mg, alternate days) with topical clindamycin gel in moderately severe acne vulgaris. J Eur Acad Dermatol Venereol 2009;23:556-560
20. Peck GL, Olsen TG, Yoder FW, Strauss JS, Downing DT, Pandya M, et al. Prolonged remissions of cystic and conglobate acne with 13-cis-retinoic acid. N Engl J Med 1979;300:329-333
21. Farrell LN, Strauss JS, Stranieri AM. The treatment of severe cystic acne with 13-cis-retinoic acid: Evaluation of sebum production and the clinical response in a multiple-dose trial. J Am Acad Dermatol 1980;3:602-611
22. Jones H, Blanc D, Cunliffe WJ. 13-cis retinoic acid and acne. Lancet 1980;2:1048-1049
23. Peck GL, Olsen TG, Butkus D, Pandya M, Arnaud-Battandier J, Gross EG, et al. Isotretinoin versus placebo in the treatment of cystic acne. A randomized double-blind study. J Am Acad Dermatol 1982;6:735-745
24. King K, Jones DH, Daltrey DC, Cunliffe WJ. A double-blind study of the effects of 13-cis-retinoic acid on acne, sebum excretion rate and microbial population. Br J Dermatol 1982;107:583-590
25. Jones DH, King K, Miller AJ, Cunliffe WJ. A dose-response study of I3-cis-retinoic acid in acne vulgaris. Br J Dermatol 1983;108:333-343
26. Stewart ME, Benoit AM, Stranieri AM, Rapini RP, Strauss JS, Downing DT. Effect of oral 13-cis-retinoic acid at three dose levels on sustainable rates of sebum secretion and on acne. J Am Acad Dermatol 1983;8:532-538
27. van der Meeren HL, van der Schroeff JG, Stijnen T, van Duren JA, van der Dries HA, van Voorst Vader PC. Doseresponse relationship in isotretinoin therapy for conglobate acne. Dermatologica 1983;167:299-303.
28. Strauss JS, Rapini RP, Shalita AR, Konecky E, Pochi PE, Comite H, et al. Isotretinoin therapy for acne: Results of a multicenter dose-response study. J Am Acad Dermatol 1984;10:490-496
29. Layton AM, Knaggs H, Taylor J, Cunliffe WJ. Isotretinoin for acne vulgaris 10 years later: A safe and successful treatment. Br J Dermatol 1993;129:292-296
30. Al Mishari MA. A study of isotretinoin (Roaccutan) in nodulocystic acne. Clin Trials J 1986;23:1-5.
31. Lehucher-Ceyrac D, Weber-Buisset MJ. Isotretinoin and acne in practice: A prospective analysis of 188 cases over 9 years. Dermatology 1993;186:123-128
32. Chivot M, Midoun H. Isotretinoin and acne-a study of relapses. Dermatologica 1990;180:240-243
33. Harms M, Masouyé I, Radeff B. The relapses of cystic acne after isotretinoin treatment are age-related: Along-term follow-up study. Dermatologica 1986;172:148-153
34. Cunliffe WJ, Norris JF. Isotretinoin-an explanation for its longterm benefit. Dermatologica 1987;175:133-137
35. Azoulay L, Oraichi D, Bérard A. Isotretinoin therapy and the incidence of acne relapse: A nested case-control study. Br J Dermatol 2007;157:1240-1248